8368 results
-
List item
Human medicine European public assessment report (EPAR): Genvoya (updated)
elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide, HIV Infections
Date of authorisation: 19/11/2015, Additional monitoring, Revision: 18, Authorised -
List item
Human medicine European public assessment report (EPAR): Entacapone Teva (updated)
entacapone, Parkinson Disease
Date of authorisation: 18/02/2011, Generic, Revision: 8, Authorised -
List item
Human medicine European public assessment report (EPAR): Feraccru (updated)
ferric maltol, Anemia, Iron-Deficiency
Date of authorisation: 18/02/2016, Revision: 7, Authorised -
List item
Human medicine European public assessment report (EPAR): Rebif (updated)
interferon beta-1a, Multiple Sclerosis
Date of authorisation: 03/05/1998, Revision: 33, Authorised -
List item
Human medicine European public assessment report (EPAR): Inhixa (updated)
enoxaparin sodium, Venous Thromboembolism
Date of authorisation: 15/09/2016, Additional monitoring, Biosimilar, Revision: 9, Authorised -
List item
Human medicine European public assessment report (EPAR): Zoledronic Acid Hospira (updated)
zoledronic acid, Hypercalcemia
Date of authorisation: 19/11/2012, Generic, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Irbesartan Teva (updated)
irbesartan, Hypertension
Date of authorisation: 30/10/2009, Generic, Revision: 10, Authorised -
List item
Human medicine European public assessment report (EPAR): Ovaleap (updated)
follitropin alfa, Anovulation
Date of authorisation: 27/09/2013, Biosimilar, Revision: 7, Authorised -
List item
Human medicine European public assessment report (EPAR): Biktarvy (updated)
bictegravir / emtricitabine / tenofovir alafenamide, HIV Infections
Date of authorisation: 21/06/2018, Additional monitoring, Revision: 1, Authorised -
List item
Human medicine European public assessment report (EPAR): Adasuve (updated)
loxapine, Schizophrenia Bipolar Disorder
Date of authorisation: 20/02/2013, Revision: 11, Authorised -
List item
Human medicine European public assessment report (EPAR): Ziagen (updated)
abacavir, HIV Infections
Date of authorisation: 08/07/1999, Revision: 36, Authorised -
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Teva Pharma (updated)
zoledronic acid, Osteoporosis Osteitis Deformans Osteoporosis, Postmenopausal
Date of authorisation: 15/08/2012, Generic, Revision: 11, Withdrawn -
List item
Human medicine European public assessment report (EPAR): Copalia HCT (updated)
amlodipine / valsartan / hydrochlorothiazide, Hypertension
Date of authorisation: 03/11/2009, Revision: 12, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Inflacam (updated)
meloxicam, Horses Dogs Cats Cattle Pigs
Date of authorisation: 09/12/2011, Generic, Revision: 7, Authorised -
List item
Human medicine European public assessment report (EPAR): Elocta (updated)
efmoroctocog alfa, Hemophilia A
Date of authorisation: 18/11/2015, Additional monitoring, Revision: 4, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Rheumocam (updated)
meloxicam, Dogs Horses Cats Cattle Pigs
Date of authorisation: 10/01/2008, Generic, Revision: 11, Authorised -
List item
Human medicine European public assessment report (EPAR): Latuda (updated)
lurasidone, Schizophrenia
Date of authorisation: 20/03/2014, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Remicade (updated)
infliximab, Spondylitis, Ankylosing Arthritis, Rheumatoid Psoriasis Crohn Disease Arthritis, Psoriatic Colitis, Ulcerative
Date of authorisation: 13/08/1999, Revision: 52, Authorised -
List item
Human medicine European public assessment report (EPAR): Exviera (updated)
dasabuvir, Hepatitis C, Chronic
Date of authorisation: 14/01/2015, Additional monitoring, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Copalia (updated)
amlodipine / valsartan, Hypertension
Date of authorisation: 15/01/2007, Revision: 22, Authorised -
List item
Human medicine European public assessment report (EPAR): Viekirax (updated)
ombitasvir / paritaprevir / ritonavir, Hepatitis C, Chronic
Date of authorisation: 14/01/2015, Additional monitoring, Revision: 16, Authorised -
List item
Human medicine European public assessment report (EPAR): Atripla (updated)
efavirenz / emtricitabine / tenofovir disoproxil, HIV Infections
Date of authorisation: 13/12/2007, Revision: 30, Authorised -
List item
Human medicine European public assessment report (EPAR): Orfadin (updated)
nitisinone, Tyrosinemias
Date of authorisation: 20/02/2005, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Afinitor (updated)
everolimus, Carcinoma, Renal Cell Breast Neoplasms Pancreatic Neoplasms
Date of authorisation: 02/08/2009, Revision: 22, Authorised -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord (updated)
aripiprazole, Schizophrenia Bipolar Disorder
Date of authorisation: 15/11/2015, Generic, Revision: 6, Authorised